Asacol HD (mesalamine) may help alleviate your moderately active ulcerative colitis symptoms
(ie, rectal bleeding and stool frequency), so you can spend more time doing the things you love.1,2

  • Moderately active UC is characterized by tougher symptoms than mildly active UC. Asacol HD
    (mesalamine) at 4.8 grams/day is proven to help treat these tougher flares of moderately active UC.2
  • In clinical studies, Asacol HD decreased UC symptoms, including frequent trips to the bathroom (ie, number of bowel movements) and rectal bleeding, for the majority of patients by three weeks. Individual results may vary.1,2,3
  • Asacol HD has a targeted delivery system that gets medicine to the colon where it is needed most.5,6
References
  • Sandborn WJ, Regula J, Feagan BG, et al. Delayed-release oral mesalamine 4.8 g/day (800 mg tablet) is effective for patients with moderately active ulcerative colitis. Gastroenterology. 2009;137(6):1934-1943.
  • Hanauer SB, Sandborn WJ, Kornbluth A, et al. Delayed-release oral mesalamine at 4.8 g/day (800 mg tablet) for the treatment of moderately active ulcerative colitis: the ASCEND II trial. Am J Gastroenterol. 2005;100(11):2478-2485.
  • Data on file. Rockaway, NJ: Warner Chilcott (US), LLC.
  • CCFS - What is Ulcerative Colitis. Available at: http://www.ccfa.org/what-are-crohns-and-colitis/what-is-ulcerative-colitis/
  • Asacol® HD [package insert]. Rockaway, NJ: Warner Chilcott (US), LLC; 2013.
  • Kornbluth A, Sarchar DB, for the Practice Parameters Committee of the American College of Gastroenterology. Ulcerative colitis practice guidelines in adults: American College of Gastroenterology, Practice Parameters Committee. Am J Gastroenterol. 2010;105(3):501-523.

Indication

Asacol® HD (mesalamine) delayed-release tablets are available only by prescription for the treatment of moderately active ulcerative colitis (UC) in adults.

Important Safety Information about Asacol® HD (mesalamine) delayed-release tablets

You should tell your doctor and you should not take Asacol® HD if you are allergic to salicylates (including mesalamine, aspirin, or aspirin-containing products) or to any of the ingredients of Asacol® HD

Reports of problems with kidney function have been associated with mesalamine-containing products like Asacol® HD. Tell your doctor if you have or have had any problems with your kidneys. It is recommended that all patients have their kidney function checked before starting Asacol® HD and periodically while on therapy.

Products that contain mesalamine, like Asacol® HD, have been associated with a condition that may be difficult to distinguish from an ulcerative colitis flare-up. Symptoms include cramping, stomach ache, bloody diarrhea, and sometimes fever, headache, and rash. If you experience any of these symptoms, talk to your doctor immediately. Your doctor may decide to discontinue your medication.

Tell your doctor if you are allergic to sulfasalazine, as you may also be allergic to Asacol® HD or drugs that contain or are converted to mesalamine. Some patients taking Asacol® HD or mesalamine-containing products have reported heart-related allergic reactions, such as inflammation of the heart muscle and inflammation of the lining of the heart. Tell your doctor if you have or have had a history of myocarditis or pericarditis as this may increase your likelihood of having these types of reactions.

Reports of liver failure have been associated with mesalamine-containing products like Asacol® HD in patients that have or have had liver disease. Tell your doctor if you have a problem with your liver.

Tell your doctor if you have a history of obstruction or a narrowing of the stomach passage leading into the small intestine, as this may delay the release of the medicine.

Asacol® HD has not been studied in pregnant women. Talk to your doctor if you are pregnant, planning to become pregnant, or are breastfeeding because Asacol® HD may not be right for you.

In clinical trials, common side effects reported with Asacol® HD included headache, runny nose, diarrhea, stomach pain, belching, flatulence, general pain, and upset stomach. Other side effects may occur.

You should not substitute one Asacol® HD 800 mg tablet for two Asacol® (mesalamine) delayed-release 400 mg tablets.

Please see Full Prescribing Information about Asacol® HD.

To report a side effect from one of our products, please call the Actavis Drug Safety Department at 1-800-272-5525.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.FDA.gov/medwatch, or call
1-800-FDA-1088.

DELZICOL® is a registered trademark of Warner Chilcott Company LLC.

Asacol® is a registered trademark of Medeva Pharma Suisse AG, used under license by Warner Chilcott Company, LLC.